MedTrace Logo

Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia

NCT03985826 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7348

Last updated 2020-12-03

No results posted yet for this study

Summary

Improved understanding of the long-time healthcare utilisation of childhood cancer survivors is relevant as it can be seen as a proxy for the population's morbidity.

The investigators will conduct a historic population-based matched cohort study using Danish nationwide registry data. Eligible children are children 1.0-17.9 years diagnosed with Acute lymphoblastic leukaemia (ALL) in Denmark from 1994 till 2016. The primary outcome is yearly contact rates to primary healthcare.

Conditions

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

OTHER

Diagnosis of and treatment for Acute lymphoblastic leukaemia in childhood

The cohort of ALL survivors has all been diagnosed and treated for ALL in childhood

Sponsors & Collaborators

  • Research Unit for General Practice, Aarhus University

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Peter Vedsted, Professor · Research Unit for General Practice, Institute for Public Health

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03985826 on ClinicalTrials.gov